Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function (ISMN)

This study has been withdrawn prior to enrollment.
(Funding)
Sponsor:
Information provided by (Responsible Party):
Corporal Michael J. Crescenz VA Medical Center
ClinicalTrials.gov Identifier:
NCT01961453
First received: October 9, 2013
Last updated: August 9, 2016
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)